T0	Interventions 92 123	cathepsin K inhibitor, ONO-5334
T1	Interventions 420 451	cathepsin K inhibitor, ONO-5334
T2	Interventions 579 699	doses of 10 to 600 mg once daily and 50 and 300 mg twice daily were evaluated in 15- and 28-day multiple-dosing cohorts.
T3	Interventions 1232 1238	days).
T4	Interventions 1239 1247	ONO-5334
T5	Interventions 1340 1353	with ONO-5334